ArticleClinical oral investigations2026
Subsequent depression in patients with lip and head and neck cancer: a population-based primary care analysis.
Article in Clinical oral investigations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLip and head and neck cancer is associated with a significant psychological burden. However, there is a lack of evidence from German primary care regarding the association between lip and head and neck cancer and subsequent depression. Our study aimed to determine the association between lip and head and neck cancer diagnosis and subsequent depression diagnosis.
methodsUsing the German Disease Analyzer database (IQVIA), we conducted a retrospective cohort study of adults (≥ 18 years) with incident lip and head and neck cancer (ICD-10 C00-C06) initially documented in general practices between 2005 and 2023. Individuals with prior mental health conditions were excluded. Lip and head and neck cancer patients were propensity-score matched (1:10) to cancer-free individuals. Incident depression diagnosis within five years after the index date was the primary outcome, analyzed using Kaplan-Meier curves and conditional Cox regression.
resultsThe study included 1,852 patients with lip and head and neck cancer and 18,520 matched non-cancer individuals. Lip and head and neck cancer was associated with a higher incidence of subsequently diagnosed depression (hazard ratio (HR) = 1.62; 95% confidence interval (CI) 1.40-1.87). Tongue cancer was found to be the tumor site most consistently associated with subsequent depression across all subgroups (HR = 2.05; 95% CI 1.65-2.53); base-of-tongue cancer (C01) and tongue cancer (C02) showed independently consistent associations when analyzed separately (HR = 2.10 and HR = 2.01, respectively). Stronger associations were observed among adults aged 60 years or younger and men. Patients with distant metastasis showed a particularly strong association with subsequent depression (HR = 2.59; 95% CI 1.85-3.63).
conclusionsPatients with lip and head and neck cancer, particularly those with tongue cancer, younger individuals, and patients with metastases, showed a significantly higher incidence of subsequent depression. These results highlight the importance of systematic mental health screening and targeted psychosocial support in routine oncological and primary care settings to enhance patient outcomes.
Indexed as
Identifiers
42782416What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.